Linzess 72 MCG capsule UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5L4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,561
Award facts
- Contract value 100% obligated
- $15,560.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,560.63 delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Linzess 72 micrograms capsules in quantities of 30 units. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.9 million through December 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 22, 2026. No set-aside designation was applied to this award, indicating full and open competition.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's IDC vehicle with DLA provides a comprehensive global pharmaceutical support mechanism enabling the delivery of a wide range of medical products—including specialty medications, vaccines, and medical supplies—to support military healthcare programs worldwide. This particular delivery order for Linzess, a gastrointestinal medication, exemplifies the company's role in supplying essential prescription pharmaceuticals across multiple therapeutic domains to federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJ5L4?
SPE2DR26FJ5L4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FJ5L4 worth?
The government has obligated $15,561 on SPE2DR26FJ5L4.
Is contract SPE2DR26FJ5L4 an order under another contract?
Yes. SPE2DR26FJ5L4 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5L4 competed?
The extent of competition for SPE2DR26FJ5L4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award